Product
Direct Oral Anticoagulant
2 clinical trials
5 indications
Indication
Intracardiac ThrombusIndication
STEMIIndication
Congestive Heart FailureIndication
cancerIndication
Non-small Cell LungClinical trial
Anticoagulant Regimens Given to Achieve Thrombus Regression and Reduce Clinical Outcomes Among Patients With Non Device-related Intra-cardiac Thrombus: a Randomized Assessment Under Direct Oral Anticoagulant and Vitamin-k Antagonist TherapyStatus: Recruiting, Estimated PCD: 2025-04-01
Clinical trial
A Phase 2, Open-Label, Parallel Cohort Study of Subcutaneous Amivantamab in Multiple Regimens in Patients With Advanced or Metastatic Solid Tumors Including EGFR-mutated Non-Small Cell Lung CancerStatus: Recruiting, Estimated PCD: 2025-10-31